Twitter Inc (NYSE:TWTR)’s chief operating officer, Ali Rowghani, has resigned from his post and won’t be replaced as CEO Dick Costolo seeks more direct involvement with the company’s engineering and product teams. Twitter Inc. said in regulatory filing Thursday that Rowghani’s responsibilities will be shifted to other executives. It did not give a reason for his departure. With the shift, Twitter joins other tech companies such as Google, Yahoo, Apple and Netflix that do not have a COO. Facebook’s Sheryl Sandberg is a notable exception. Twitter Inc (NYSE:TWTR) net profit margin is -93.70% and weekly performance is 8.56%. On last trading day company shares ended up $36.79. Analysts mean target price for the company is $43.73. Twitter Inc (NYSE:TWTR) distance from 50-day simple moving average (SMA50) is -2.02%.
Express Inc. (EXPR), a struggling clothing retailer that targets shoppers in their 20s, soared as much as 33 percent in late tr(NYSE:EXPR) ading yesterday after Sycamore Partners said it’s interested in acquiring the company. Sycamore, which has amassed a 9.9 percent stake in Express, said in a letter to the retailer’s board that it would like to perform due diligence to determine a takeover price. Though Express responded by adopting a poison-pill defense, Sycamore’s interest sent the shares as high as $18 after hours. Express, Inc. (NYSE:EXPR) shares fell -2.59% in last trading session and ended the day on $13.55. Gross Margin is 32.30% and its return on assets is 10.40%. Express, Inc. (NYSE:EXPR) quarterly performance is -14.99%.
OraSure Technologies Inc (NASDAQ:OSUR) was downgraded by analysts at TheStreet from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday. OraSure Technologies, Inc. (NASDAQ:OSUR) shares moved up 4.28% in last trading session and was closed at $7.80, while trading in range of $7.38 – $7.82. OraSure Technologies, Inc. (NASDAQ:OSUR) year to date (YTD) performance is 24.01%.
June 3, 2014 — MELA Sciences, Inc. (NASDAQ:MELA), developer of the MelaFind(R) system, an optical diagnostic device approved for use in the United States and the European Union to assist dermatologists in melanoma diagnosis, announced that it has initiated a study to examine the real-world clinical impact of MelaFind on dermatologists’ decision to biopsy pigmented skin lesions that are suspicious for melanoma. Darrell Rigel, MD, MS, Clinical Professor of Dermatology at New York University Langone Medical Center, will be the Principle Investigator for the study. MELA Sciences Inc (NASDAQ:MELA) ended the last trading day at $0.380. Company weekly volatility is calculated as 11.49% and price to cash ratio as 2.45. MELA Sciences Inc (NASDAQ:MELA) showed a positive weekly performance of 15.15%.
Becton, Dickinson and Co. (NYSE:BDX) a leading global medical technology company, announced its launch of the BD BACTEC™ FX40 Blood Culture System with connectivity to the BD EpiCenter™ Microbiology Data Management System. This communication enables access to advanced reporting capabilities, connectivity to the hospital’s Laboratory Information System (LIS) and access to the unique BD Blood Volume Monitoring Software. Becton, Dickinson and Co. (NYSE:BDX) net profit margin is 11.50% and weekly performance is -0.48%. On last trading day company shares ended up $118.20. Analysts mean target price for the company is $118.54. Becton, Dickinson and Co. (NYSE:BDX) distance from 50-day simple moving average (SMA50) is 2.65%.
Leave a Reply